D. Western Therapeutics Institute (TSE:4576) Total Current Liabilities: 円203.88 Mil (As of Dec. 2025)


TSE:4576 D. Western Therapeutics Institute Inc TSE:4576
44 GF Score
Price 円77.00
GF Value 円63.91
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is D. Western Therapeutics Institute Total Current Liabilities?

D. Western Therapeutics Institute TSE:4576 -6.10% 44 Total Current Liabilities is 円203.88 Mil as of Dec. 2025. GuruFocus rates TSE:4576 with a GF Score™ of 44/100 and a GF Value™ of 円63.91 (Modestly Overvalued). The stock has 3 warning signs investors should review.

Total current liabilities includes Accounts Payable & Accrued Expense, Short-Term Debt & Capital Lease Obligation, Other Current Liabilities, and Current Deferred Liabilities. D. Western Therapeutics Institute's total current liabilities for the quarter that ended in Dec. 2025 was 円203.88

Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term.

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term

D. Western Therapeutics Institute Total Current Liabilities Related Terms

D. Western Therapeutics Institute Total Current Liabilities Historical Data

* Premium members only.

The historical data trend for D. Western Therapeutics Institute's Total Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

D. Western Therapeutics Institute Total Current Liabilities Chart

D. Western Therapeutics Institute Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 193.25 211.21 194.01 132.65 203.88

D. Western Therapeutics Institute Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Dec25 Mar26
Total Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 132.65 83.11 105.99 203.88 162.64
TSE:4576
44GF Score
D. Western Therapeutics Institute Inc TSE:4576
Total Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

D. Western Therapeutics Institute Total Current Liabilities Calculation

Total Current Liabilities is the total amount of liabilities that the company needs to pay over the next 12 months.

D. Western Therapeutics Institute's Total Current Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=66.998+99.048
+Other Current Liabilities+Current Deferred Liabilities
=37.836+0
=203.88

D. Western Therapeutics Institute's Total Current Liabilities for the quarter that ended in Dec. 2025 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=66.998+99.048
+Other Current Liabilities+Current Deferred Liabilities
=37.836+0
=203.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The increase of Total Current Liabilities of a company is not necessarily a bad thing. This may conserve the company's cash and contribute positively to cash flow.

Total Current Liabilities is linked to Total Current Assets through the Current Ratio and Working Capital. The Current Ratio is equal to dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations. Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

What does a Total Current Liabilities of 円203.88 Mil mean?
D. Western Therapeutics Institute (TSE:4576) has a Total Current Liabilities of 円203.88 Mil as of Dec. 2025. The total amount of liabilities with maturity less than one year as recorded on a company's balance sheet. View historical data for D. Western Therapeutics Institute and its competitors.
Is D. Western Therapeutics Institute's Total Current Liabilities too high?
D. Western Therapeutics Institute's current Total Current Liabilities is 円203.88 Mil. Overall, D. Western Therapeutics Institute has a GF Score™ of 44/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does D. Western Therapeutics Institute's Total Current Liabilities compare to VRTX and REGN?
D. Western Therapeutics Institute's Total Current Liabilities of 円203.88 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Current Liabilities for a Biotechnology company?
A good Total Current Liabilities depends on the Biotechnology industry context. However, Total Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Current Liabilities mean?
A high Total Current Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities with maturity less than one year as recorded on a company's balance sheet. View historical data for D. Western Therapeutics Institute and its competitors. D. Western Therapeutics Institute's current Total Current Liabilities is 円203.88 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is D. Western Therapeutics Institute stock overvalued right now?
Based on GuruFocus' analysis, D. Western Therapeutics Institute (TSE:4576) is currently considered Modestly Overvalued. The stock's GF Value™ is 円63.91, compared to a current price of 円77.00 — trading 20.5% above its estimated fair value. The current Total Current Liabilities is 円203.88 Mil. D. Western Therapeutics Institute's overall GF Score™ is 44/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Current Liabilities calculated?
Total Current Liabilities is calculated from a company's financial statements. For D. Western Therapeutics Institute (TSE:4576), the current Total Current Liabilities is 円203.88 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is D. Western Therapeutics Institute (TSE:4576) Overvalued in 2026?

Based on GuruFocus' analysis, D. Western Therapeutics Institute stock appears to be overvalued. The current stock price of 円77.00 is trading 20.5% above its estimated GF Value™ of 円63.91. GuruFocus considers D. Western Therapeutics Institute to be Modestly Overvalued.

Key valuation signals for TSE:4576:

  • Total Current Liabilities: 円203.88 Mil
  • GF Value™: 円63.91 vs. price of 円77.00 (20.5% above fair value)
  • GF Score™: 44/100 with 3 warning signs

No single metric tells the full story. See the TSE:4576 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

D. Western Therapeutics Institute Business Description

Other Exchanges 6DW:Germany
Address 7th Floor, 18 KT Bulding, 1-18-11, Nishiki, Naka-ku, Aichi, Nagoyashi, JPN, 460-0003
D. Western Therapeutics Institute Inc is engaged in the research and development of pharmaceutical drugs in Japan. Its products include ophthalmic solution and agents for antiplatelet and anti-glaucoma.
44GF Score

Get the complete analysis for TSE:4576

Total Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円77.00
Price
円63.91
GF Value